Literature DB >> 23591854

[Peritoneal dialysis from the beginnings up to today: which developments of the last decades were important?].

Andreas Vychytil1.   

Abstract

During the past years new developments in peritoneal dialysis (PD) technique have resulted in continuous improvement of patient outcome. The importance of salt and fluid balance, residual renal function and peritoneal glucose load are of increasing interest, whereas small solute clearances have lost importance. In patients with high peritoneal transport rates automated PD (APD) is indicated. However, APD can also be chosen as initial PD treatment since recent studies show comparable or even better survival as compared to continuous ambulatory PD patients. Alternative PD solutions improve peritoneal ultrafiltration (icodextrin), reduce peritoneal glucose load (amino acid solution, icodextrin) and protect the peritoneal membrane (solutions with low concentration of glucose degradation products). Infection risk can be reduced when using antibiotic creams, but resistances should be considered. Ongoing studies will clarify if non-antibiotic agents, e.g. medihoney, are effective in preventing PD-associated infections. Due to these improvements PD and hemodialysis have become equivalent treatments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591854     DOI: 10.1007/s10354-013-0191-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  106 in total

1.  II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients.

Authors:  Tansu Sav; Mehmet Tugrul Inanc; Ali Dogan; Oktay Oymak; Cengiz Utas
Journal:  Nephrology (Carlton)       Date:  2010-04       Impact factor: 2.506

3.  Effect of icodextrin dialysis solution on body weight and fat accumulation over time in CAPD patients.

Authors:  Kyu-Hyang Cho; Jun-Young Do; Jong-Won Park; Kyung-Woo Yoon
Journal:  Nephrol Dial Transplant       Date:  2009-09-19       Impact factor: 5.992

4.  Survival advantage of icodextrin peritoneal dialysis solution in a time-dependent model.

Authors:  Song Vogue Ahn; Edward Vonesh; Seung Hyeok Han
Journal:  Am J Kidney Dis       Date:  2012-11-14       Impact factor: 8.860

5.  Rapid decline of residual renal function in patients on automated peritoneal dialysis.

Authors:  K Hiroshige; K Yuu; M Soejima; M Takasugi; A Kuroiwa
Journal:  Perit Dial Int       Date:  1996 May-Jun       Impact factor: 1.756

6.  Quality of life in automated and continuous ambulatory peritoneal dialysis.

Authors:  Wieneke M Michels; Sandra van Dijk; Marion Verduijn; Saskia le Cessie; Elisabeth W Boeschoten; Friedo W Dekker; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2011-02-28       Impact factor: 1.756

Review 7.  Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.

Authors:  Giovanni F M Strippoli; Allison Tong; David Johnson; Francesco P Schena; Jonathan C Craig
Journal:  Am J Kidney Dis       Date:  2004-10       Impact factor: 8.860

8.  Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure.

Authors:  S Müller-Krebs; L P Kihm; B Zeier; M L Gross; R Deppisch; A Wieslander; T Henle; I Penndorf; J Oh; J Reiser; P P Nawroth; M Zeier; V Schwenger
Journal:  Eur J Clin Invest       Date:  2008-03-16       Impact factor: 4.686

9.  Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database.

Authors:  Sharon J Nessim; Joanne M Bargman; Peter C Austin; Rosane Nisenbaum; Sarbjit V Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

10.  Automated and continuous ambulatory peritoneal dialysis have similar outcomes.

Authors:  S V Badve; C M Hawley; S P McDonald; D W Mudge; J B Rosman; F G Brown; D W Johnson
Journal:  Kidney Int       Date:  2007-11-28       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.